MedTrace Logo

Effect of Ca2+ Ionophore on Embryonic Development and Clinical Outcome in Cases With Previous Fertilization Arrest

NCT02683031 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-08-18

No results posted yet for this study

Summary

We aimed to investigate the efficiency of chemical oocyte activation using readymade Ca2+ ionophore on cases with previously cancelled cases due to fertilization arrest at pronuclear stage i.e: cleavage failure to find out if there is any improvement in embryonic developmental stages.

Conditions

  • Fertilization Arrest

Interventions

OTHER

Ca2+ ionophore

Ca2+ ionophore is a chemical agent used to perform oocyte activation after ICSI. It showed effective treatment to get better fertilization, pregnancy, and healthy livebirth in cases with total or partial fertilization failure.

Sponsors & Collaborators

  • Benha University

    collaborator OTHER

  • TopLab Company for ART Laboratories Consultation and Training

    lead OTHER

Principal Investigators

  • Yasmin Magdi, M.Sc · Dar Almaraa fertility and gynacology center

  • Mona M. Awady, MD · Department of Community Medicine, Faculty of Medicine, Benha University, Benha, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02683031 on ClinicalTrials.gov